Table 2.

AVP, CRH and GR mRNA in the PVN and POMC mRNA levels in the anterior pituitary for oil-SHOVX, oil-OVXE₂, TP-SHOVX and TP-OVXE₂ female rats (Mean ±s.e.m, n = 7–8)

Treatment group	AVP mRNA (%±s.e.m. of Oil-SHOVX controls)	CRH mRNA (%±s.e.m. of Oil-SHOVX controls)	GR mRNA (%±s.e.m. of Oil-SHOVX controls)	POMC mRNA (%±s.e.m. of Oil-SHOVX controls)
Oil-SHOVX	100 (9)	100 (12)	100 (9)	100 (13)
Oil-OVXE2	101.2 (11)	97.2 (13)	96.3 (7)	114 (15)
TP-SHOVX	65.4 (8)*†‡	51.5 (10)***††‡	150.9 (8)**†	47.3 (10)***†††‡
TP-OVXE2	96.3 (11)	90 (14)	114.4 (8)	89.5 (14)

TP-SHOVX rats demonstrated significantly lower levels of AVP, CRH and POMC mRNA compared to the remaining groups and significantly greater levels of PVN GR mRNA compared to oil-treated controls.

^*P < 0.05;

^**P < 0.01.

^***P < 0.001 compared to oil-SHOVX;

^†P < 0.05;

^††P < 0.01;

^†††P < 0.001 compared to oil-OVXE₂;

^‡P < 0.05 compared to TP-OVXE₂ rats.